RE:RE:Do you guys now understand? Good morning, that is the million dollar question. If phase 1 is actually done and onto 2a I don't truly know a timeline. My thoughts are if we can pass phase 2a with good results the stock should in theory spike because we are closer to treating the sick from COVID-19 as well as closer to a product on the shelf. Companies will gamble with cash more when 2a is passed I would believe. I don't think we will see .94 cents pre RS value but it should rise. Problem is COVID-19 recovery rates are extremely high for most without any treatment or hospitalization. Also MicroPEA is only unique until 2030. The largest shock of COVID-19 is peaked and how much money will a company pay for a product that's quickly expiring. If 2021 they could pass all testing that's probably worth more than 2023 because of patent expiry. 7 years on the shelf as opposed to 9 years is probably a big deal. Originally I thought Dr R said this should be done phase 2B in 2023 but please don't hold me to that. Going by memory not data. I don't know if this can be accelerated at all with everything going on. If anyone has REAL data on this we would love to know. Please share!
MoneyTalks7 wrote: Good morning BigMac, thanks for the analysis. It's great when everyone shares their thoughts in a constructive manner, overall it makes us better informed investors. You mention after phase 2a we will see movement, and that should only be cause for celebration. BigMac, my only dilemma is ----what am I going to wear for this big event?